Niche sampling OPS Diagnostics focuses on sample preservation and homogenization with bench to high-throughput workflows, presenting an opportunity to upsell scalable nucleic acid isolation chemistries and lyophilization reagents to labs expanding throughput.

Customizable solutions Their emphasis on tailoring products to customer needs suggests sales messaging should highlight flexible kit configurations, custom protocols, and lab-specific application support to win partnerships with research institutes and biotech developers.

SMB growth potential With 11-50 employees and revenue in the 10–25 million range, OPS is a mid-market biotech supplier ripe for multi-product deals, channel partnerships, and contract manufacturing or private label opportunities with larger distributors.

Founder-led advantage Dr. David Burden’s deep microbiology and molecular genetics expertise can be leveraged in thought leadership outreach, joint webinars, and collaborative product development to accelerate adoption among researchers and pilot programs.

Global tech stack Leverage their digital footprint and cloud-based operations (AWS, Google tools, Cloudflare) for targeted digital campaigns and integration partnerships, aiming to expand reach to labs adopting high-throughput workflows and automation.